Medvin Clinical Research
Tujunga, California, United States
Research institute in Whittier, California
12456 Washington Blvd, Whittier, CA 90602
About Medvin Clinical Research
"Your health is our #1 Priority. Medvin Clinical Research is a multi-specialty, multi-facility Research Company based in Los Angeles, California that has been conducting clinical trials in Rheumatology, Gastroenterology, Cardiology and Internal medicine among other indications since 2006. We have successfully completed in excess of 130 trials and helped over a 3000 patients achieve the quality of life that they deserve."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bristol-Myers Squibb
2
Horizon Therapeutics Ireland DAC
2
Anika Therapeutics, Inc.
1
Eli Lilly and Company
1
Ironwood Pharmaceuticals, Inc.
1
Janssen Research & Development, LLC
1
Kiniksa Pharmaceuticals, Ltd.
1
Clinical Trials at Medvin Clinical Research
During the past decade, Medvin Clinical Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
2017-07-19
2019-02-25
Terminated
242
Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)
2019-04-01
2021-01-27
Completed
203
Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout
2019-06-13
2022-04-11
Completed
152
A Study of Baricitinib in Participants With Rheumatoid Arthritis
2020-02-14
2026-02-01
Recruiting
1,300
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
2020-01-07
2022-12-05
Completed
112
Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain
2020-09-11
2022-05-16
Completed
231
Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
2020-10-02
2024-12-01
Recruiting
180
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
2021-09-28
2026-09-07
Recruiting
450
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Medvin Clinical Research" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Horizon Therapeutics Ireland DAC" with 2 trials
sponsored, "Anika Therapeutics, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Ironwood Pharmaceuticals, Inc."
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Medvin Clinical Research"
#1 collaborator was "Incyte Corporation" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Medvin Clinical Research
According to Clinical.Site data, the most researched conditions in "Medvin Clinical Research" are
"Gout" (3 trials), "Rheumatoid Arthritis" (2 trials), "Active Psoriatic Arthritis" (1 trials), "Arthritis, Psoriatic" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Medvin Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Medvin Clinical Research
Most popular intervention types in "Medvin Clinical Research" are "Drug" (8 trials), "Biological" (2 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "BMS-986165 Dose A" (1 trials), "BMS-986165 Dose B" (1 trials), "BMS-986165 Placebo" (1 trials) and "Baricitinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medvin Clinical Research
The vast majority of trials in "Medvin Clinical Research" are
9 trials for "All" genders.
Clinical Trials Status at Medvin Clinical Research
Currently, there are NaN active trials in "Medvin Clinical Research".
undefined are not yet recruiting,
4 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Medvin Clinical Research,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Medvin Clinical Research, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 0 trials that are defined as “Not Applicable".